Skip Navigation
National Cancer Institute
U.S. National Institutes of Health www.cancer.gov
The caBIG program has been retired, and while this website is being maintained temporarily to prevent broken links and provide access to information on the subset of caBIG projects that were transitioned into the new NCIP program, it will be archived in the near future. For information on the NCI's biomedical informatics program, please visit http://ncip.nci.nih.gov.

 

NCI Cancer Centers Program

caBIG® has connected 50 NCI-designated Cancer Centers into a national network (caGrid) to create the world's largest biomedical research "highway." (See your Center at http://cagrid-portal.nci.nih.gov/web/guest/home).

Connecting the Community
caBIG® was conceived, designed, and developed in partnership with the NCI-Designated Cancer Centers to solve basic and clinical research challenges through the use of state-of-the-art information technology, and to create an interoperable infrastructure to eliminate data disconnects that have traditionally slowed the pace of translational research.

Fostering Growth
A structured deployment process was begun in 2007 to help participating centers "Get Connected" to caBIG®. Deploying Centers receive resources and support to achieve caBIG® interoperability by adopting caBIG® tools and infrastructure, or by adapting existing systems to be caBIG®-compatible. Teams from the Cancer Centers and their communities continue to be actively involved in the ongoing development of caBIG® tools and resources.

Enhancing Capabilities
Today, those Centers use caBIG® to achieve some or all of the following critical functions:

About the NCI-Designated Cancer Centers
The NCI Cancer Centers Program supports a national network of 66 NCI-designated Cancer Centers that are engaged in collaborative, multi-disciplinary research to prevent, treat, and cure cancer. While Cancer Centers are highly diverse in size and scope, they have similar challenges and objectives. Their overarching goals include achieving significant advancements in risk assessment, prediction, prognosis, biomarkers, drug development, and customized therapy for improved clinical outcomes, via data sharing, analysis, mining and improved regulatory and security processes. To learn more about the NCI-Designated Cancer Centers Program, click here.